Corcept Therapeutics, Inc. (CORT)
58.14
+1.06
(+1.86%)
USD |
NASDAQ |
May 14, 16:00
58.14
0.00 (0.00%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Quarterly) : 637.99M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 45.88B |
| Supernus Pharmaceuticals, Inc. | 1.077B |
| Terns Pharmaceuticals, Inc. | 1.007B |
| Nektar Therapeutics | 576.22M |
| Pacira Biosciences, Inc. | 653.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 814.88M |
| Total Liabilities (Quarterly) | 176.89M |
| Debt to Equity Ratio | 0.0151 |
| Current Ratio | 2.826 |
| Net Debt Paydown Yield | -0.01% |